4.4 Article

Calculate protein-ligand binding affinities with the extended linear interaction energy method: application on the Cathepsin S set in the D3R Grand Challenge 3

Journal

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
Volume 33, Issue 1, Pages 105-117

Publisher

SPRINGER
DOI: 10.1007/s10822-018-0162-6

Keywords

MM; GBSA; Alchemical free energy calculations; Binding mode; Binding affinity; Virtual screening; Lead identification; Lead optimization

Funding

  1. National Institutes of Health of USA [R01-GM079383, R21-GM097617, P30 DA035778-01A1]
  2. Extreme Science and Engineering Discovery Environment [CHE090098]

Ask authors/readers for more resources

We participatedin the Cathepsin S (CatS) sub-challenge of the Drug Design Data Resource (D3R) Grand Challenge 3 (GC3) in 2017 to blindly predict the binding poses of 24 CatS-bound ligands, the binding affinity ranking of 136 ligands, and the binding free energies of a subset of 33 ligands in Stage 1A and Stage 2. Our submitted predictions ranked relatively well compared to the submissions from other participants. Here we present our methodologies used in the challenge. For the binding pose prediction, we employed the Glide module in the Schrodinger Suite 2017 and AutoDock Vina. For the binding affinity/free energy prediction, we carried out molecular dynamics simulations of the complexes in explicit water solvent with counter ions, and then estimated the binding free energies with our newly developed model of extended linear interaction energy (ELIE), which is inspired by two other popular end-point approaches: the linear interaction energy(LIE) method, and the molecular mechanics with Poisson-Boltzmann surface area solvation method(MM/PBSA). Our studies suggest that ELIE is a good trade-off between efficiency and accuracy, and it is appropriate for filling the gap between the high-throughput docking and scoring methods and the rigorous but much more computationally demanding methods like free energy perturbation(FEP) or thermodynamics integration(TI) in computer-aided drug design (CADD)projects.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available